Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company imports and distributes veterinary medicines at wholesale.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 2,912 | 3,423 | 4,687 | 6,245 | 7,136 | 8,845 | 11,860 | 21,829 | +33.3% | |
| Total COGS | 1,586 | 1,975 | 3,060 | 4,085 | 4,338 | 4,627 | 6,211 | 11,742 | +33.1% |
| Gross Profit | 1,325 | 1,447 | 1,627 | 2,160 | 2,798 | 4,218 | 5,649 | 10,087 | +33.6% |
| Gross Margin | 45.5% | 42.3% | 34.7% | 34.6% | 39.2% | 47.7% | 47.6% | 46.2% | |
| 524 | 576 | 939 | 1,123 | 1,419 | 1,773 | 2,345 | 2,956 | +28.1% | |
| EBITDA | 802 | 872 | 687 | 1,037 | 1,379 | 2,446 | 3,304 | 7,131 | +36.6% |
| EBITDA Margin | 27.5% | 25.5% | 14.7% | 16.6% | 19.3% | 27.7% | 27.9% | 32.7% | |
| Total D&A | 26 | 31 | 75 | 77 | 73 | 95 | 98 | 82 | +18.0% |
| EBIT / Operating Income | 776 | 840 | 612 | 960 | 1,307 | 2,351 | 3,205 | 7,049 | +37.0% |
| 0 | 22 | 29 | 144 | 183 | 27 | 103 | 7 | nmf | |
| Profit Before Tax | 776 | 819 | 583 | 1,104 | 1,490 | 2,378 | 3,308 | 7,056 | +37.1% |
| Total Income Tax | 0 | 0 | 0 | 229 | 161 | 275 | 318 | 505 | +21.8% |
| Net Profit / (Loss) | 795 | 819 | 583 | 740 | 1,168 | 2,103 | 2,990 | 6,552 | +35.2% |
| Net Margin | 27.3% | 23.9% | 12.4% | 11.9% | 16.4% | 23.8% | 25.2% | 30.0% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →